Upregulation of eNOS and unchanged energy metabolism in increased susceptibility of the aging type 2 diabetic GK rat heart to ischemic injury

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 5, 2010, Pages

  Desrois, Martine ^a   Clarke, Kieran ^c   Lan, Carole ^a   Dalmasso, Christiane ^a   Cole, Mark ^c   Portha, Bernard ^b   Cozzone, Patrick J ^a   Bernard, Monique ^a  

^a University of Aix Marseille   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cardiac ischemia reperfusion; Endothelial nitric oxide synthase; Energy metabolism; Goto Kakizaki rats; Nitric oxide; Type 2 diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PH; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DISEASE PREDISPOSITION; ENERGY METABOLISM; GOTO KAKIZAKI RAT; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

AGING; ANIMALS; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; HEART; MALE; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, MUTANT STRAINS; RATS, WISTAR; REGIONAL BLOOD FLOW; UP-REGULATION;

EID: 78249274638     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00998.2009     Document Type: Article

References (74)

1. Aasum E, Hafstad AD, Severson DL, Larsen TS. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 52: 434-441, 2003.
2. Abdul-Ghani MA, DeFronzo RA. Mitochondrial dysfunction, insulin resistance, type 2 diabetes mellitus. Curr Diab Rep 8: 173-178, 2008.
3. Abdul-Ghani MA, Muller FL, Liu Y, Chavez AO, Balas B, Zuo P, Chang Z, Tripathy D, Jani R, Molina-Carrion M, Monroy A, Folli F, Van Remmen H, DeFronzo RA. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance. Am J Physiol Endocrinol Metab 295: E678-E685, 2008.
4. Almind K, Dorio A, Kahn CR. Putting the genes for type II diabetes on the map. Nat Med 7: 277-279, 2001.
5. Bernard M, Caus T, Sciaky M, Lan C, Cozzone PJ. Optimized cardiac graft preservation: a comparative experimental study using P-31 magnetic resonance spectroscopy and biochemical analyses. J Heart Lung Transplant 18: 572-581, 1999.
6. Bisbis S, Bailbe D, Tormo MA, Picarel-Blanchot F, Derouet M, Simon J, Portha B. Insulin resistance in the GK rat: decreased receptor number but normal kinase activity in liver. Am J Physiol Endocrinol Metab 265: E807-E813, 1993.
7. Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur J Pharmacol 511: 53-64, 2005. (Pubitemid 40380644)
8. Bollano E, Omerovic E, Svensson H, Waagstein F, Fu M. Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats. Int J Cardiol 114: 195-201, 2007.
9. Bulhak AA, Jung C, Ostenson CG, Lundberg JO, Sjoquist PO, Pernow J. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am J Physiol Heart Circ Physiol 296: H719-H727, 2009.
10. Caglayan E, Stauber B, Collins AR, Lyon CJ, Yin F, Liu J, Rosenkranz S, Erdmann E, Peterson LE, Ross RS, Tangirala RK, Hsueh WA. Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis. Diabetes 57: 2470-2479, 2008.
11. Chandler MP, Morgan EE, McElfresh TA, Kung TA, Rennison JH, Hoit BD, Young ME. Heart failure progression is accelerated following myocardial infarction in type 2 diabetic rats. Am J Physiol Heart Circ Physiol 293: H1609-H1616, 2007.
12. Chatham JC. The effect of diabetes on myocardial glucose metabolism. In: The Heart in Diabetes, edited by Chatham JC, Forder JR, McNeill JH. Norwell, MA: Kluwer, 1996, p. 215-251.
13. Chatham JC, Seymour AML. Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovasc Res 55: 104-112, 2002.
14. Chen H, Higashino H, Kamenov ZA, Azuma M, Lee WH, Yang XQ, Zhou DJ, Yuan WJ. Preserved postischemic heart function in sucrose-fed type 2 diabetic OLETF rats. Life Sci 72: 2839-2851, 2003.
15. Cheng ZJ, Vaskonen T, Tikkanen I, Nurminen K, Ruskoaho H, Vapaatalo H, Muller D, Park JK, Luft FC, Mervaala EM. Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension 37: 433-439, 2001.
16. Clements RT, Sodha NR, Feng J, Boodhwani M, Liu Y, Mieno S, Khabbaz KR, Bianchi C, Sellke FW. Impaired coronary microvascular dilation correlates with enhanced vascular smooth muscle MLC phosphorylation in diabetes. Microcirculation 16: 193-206, 2009.
17. 2+ loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 283: H481-H489, 2002.
18. Deng JY, Huang JP, Lu LS, Hung LM. Impairment of cardiac insulin signaling and myocardial contractile performance in high-cholesterol/fructose- fed rats. Am J Physiol Heart Circ Physiol 293: H978-H987, 2007.
19. Desrois M, Caus T, Belles PM, Dalmasso C, Lan C, Cozzone PJ, Bernard M. Limitation of myocardial and endothelial injury of the rat heart graft after preservation with Centre de Resonance Magnetique Biologique et Medicale (CRMB) solution. Transpl Int 21: 276-283, 2008.
20. Desrois M, Caus T, Dalmasso C, Lan C, Cozzone PJ, Bernard M. Expression of the three nitric oxide synthase isoforms and nitric oxide level in the rat heart during cold storage and blood reperfusion. Cell Mol Biol Suppl 55: OL1208-1214, 2009.
21. Desrois M, Sciaky M, Lan C, Cozzone PJ, Bernard M. L-Arginine during long-term ischemia: effects on cardiac function, energetic metabolism and endothelial damage. J Heart Lung Transplant 19: 367-376, 2000. (Pubitemid 30211660)
22. Desrois M, Sciaky M, Lan C, Cozzone PJ, Bernard M. Preservation of amino acids during long term ischaemia and subsequent reflow with supplementation of L-arginine, the nitric oxide precursor, in the rat heart. Amino Acids 24: 141-148, 2003. (Pubitemid 36407957)
23. Desrois M, Sidell RJ, Gauguier D, Davey CL, Radda GK, Clarke K. Gender differences in hypertrophy, insulin resistance and ischemic injury in the aging type 2 diabetic rat heart. J Mol Cell Cardiol 37: 547-555, 2004. (Pubitemid 38953382)
24. Desrois M, Sidell RJ, Gauguier D, King LM, Radda GK, Clarke K. Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart. Cardiovasc Res 61: 288-296, 2004. (Pubitemid 38091769)
25. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, Romijn JA, de Roos A, Radder JK. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 42: 328-335, 2003. (Pubitemid 36851426)
26. Diamant M, Lamb HJ, Smit JW, de Roos A, Heine RJ. Diabetic cardiomyopathy in uncomplicated type 2 diabetes is associated with the metabolic syndrome and systemic inflammation. Diabetologia 48: 1669-1670, 2005. (Pubitemid 41175522)
27. El-Omar MM, Lord R, Draper NJ, Shah AM. Role of nitric oxide in posthypoxic contractile dysfunction of diabetic cardiomyopathy. Eur J Heart Fail 5: 229-239, 2003. (Pubitemid 37011850)
28. Elrod JW, Greer JJ, Bryan NS, Langston W, Szot JF, Gebregzlabher H, Janssens S, Feelisch M, Lefer DJ. Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 26: 1517-1523, 2006. (Pubitemid 44288977)
29. Fujita A, Sasaki H, Ogawa K, Okamoto K, Matsuno S, Matsumoto E, Furuta H, Nishi M, Nakao T, Tsuno T, Taniguchi H, Nanjo K. Increased gene expression of antioxidant enzymes in KKAy diabetic mice but not in STZ diabetic mice. Diabetes Res Clin Pract 69: 113-119, 2005. (Pubitemid 40943474)
30. Gaborit B, Kober F, Moro P, Jacquier A, Vignaud A, Dadoun F, Cozzone PJ, Bernard M, Dutour A. CMR assessment of epicardial fat volume in human morbid obesity at 3 T: relationship to cardiac function and morphology (Abstract). J Cardiovasc Magnetic Reson 12: 268, 2010.
31. Galderisi M, Capaldo B, Sidiropulos M, D'Errico A, Ferrara L, Turco A, Guarini P, Riccardi G, de Divitiis O. Determinants of reduction of coronary flow reserve in patients with type 2 diabetes mellitus or arterial hypertension without angiographically determined epicardial coronary stenosis. Am J Hypertens 20: 1283-1290, 2007. (Pubitemid 350161828)
32. Gill RM, Braz JC, Jin N, Etgen GJ, Shen W. Restoration of impaired endothelium-dependent coronary vasodilation in failing heart: role of eNOS phosphorylation and CGMP/cGK-I signaling. Am J Physiol Heart Circ Physiol 292: H2782-H2790, 2007. (Pubitemid 47084527)
33. Goto YKM, Masaki N. Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 119: 85-90, 1976.
34. Greer JJ, Ware DP, Lefer DJ. Myocardial infarction and heart failure in the db/db diabetic mouse. Am J Physiol Heart Circ Physiol 290: H146-H153, 2006.
35. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229-234, 1998.
36. Howarth FC, Jacobson M, Shafiullah M, Adeghate E. Long-term effects of type 2 diabetes mellitus on heart rhythm in the Goto-Kakizaki rat. Exp Physiol 93: 362-369, 2008.
37. Howarth FC, Shafiullah M, Qureshi MA. Chronic effects of type 2 diabetes mellitus on cardiac muscle contraction in the Goto-Kakizaki rat. Exp Physiol 92: 1029-1036, 2007.
38. Iltis I, Kober F, Desrois M, Dalmasso C, Lan C, Portha B, Cozzone PJ, Bernard M. Defective myocardial blood flow and altered function of the left ventricle in type 2 diabetic rats: a noninvasive in vivo study using perfusion and cine magnetic resonance imaging. Invest Radiol 40: 19-26, 2005.
39. Iozzo P, Lautamaki R, Borra R, Lehto HR, Bucci M, Viljanen A, Parkka J, Lepomaki V, Maggio R, Parkkola R, Knuuti J, Nuutila P. Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab 94: 4472-4482, 2009.
40. Jesmin S, Zaedi S, Maeda S, Yamaguchi I, Goto K, Miyauchi T. Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats. Exp Biol Med (Maywood) 231: 925-931, 2006. (Pubitemid 43845554)
41. Kazuyama E, Saito M, Kinoshita Y, Satoh I, Dimitriadis F, Satoh K. Endothelial dysfunction in the early- and late-stage type-2 diabetic Goto-Kakizaki rat aorta. Mol Cell Biochem 332: 95-102, 2009.
42. Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res 79: 363-380, 1996.
43. Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT, Botker HE, Flyvbjerg A. Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia 47: 1716-1721, 2004.
44. Lazzarino G, Pierro DD, Tavazzi B, Cerroni L, Giardina B. Simultaneous separation of malondialdehyde, ascorbic acid, and adenine nucleotide derivatives from biological samples by ion-pairing high-performance liquid chromatography. Anal Biochem 197: 191-196, 1991.
45. Lefevre G, Beljean-Leymarie M, Beyerle F, Bonnefont-Rousselot D, Cristol JP, Therond P, Torreilles J. Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances. Ann Biol Clin (Paris) 56: 305-319, 1998.
46. Lingvay I, Raskin P, Szczepaniak LS. The fatty hearts of patients with diabetes. Nat Rev Cardiol 6: 268-269, 2009.
47. Lloyd SG, Wang P, Zeng H, Chatham JC. Impact of low-flow ischemia on substrate oxidation and glycolysis in the isolated perfused rat heart. Am J Physiol Heart Circ Physiol 287: H351-H362, 2004.
48. Lopaschuk GD. Fatty acid metabolism in the heart following diabetes. In: The Heart in Diabetes, edited by Chatham JC, Forder JR, McNeill JH. Norwell, MA: Kluwer, 1996, p. 215-251.
49. Massion PB, Dessy C, Desjardins F, Pelat M, Havaux X, Belge C, Moulin P, Guiot Y, Feron O, Janssens S, Balligand JL. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation 110: 2666-2672, 2004.
50. Massion PB, Feron O, Dessy C, Balligand JL. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93: 388-398, 2003.
51. McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, Levine BD, Raskin P, Victor RG, Szczepaniak LS. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116: 1170-1175, 2007.
52. Ozer MK, Parlakpinar H, Cigremis Y, Ucar M, Vardi N, Acet A. Ischemia-reperfusion leads to depletion of glutathione content and augmentation of malondialdehyde production in the rat heart from overproduction of oxidants: can caffeic acid phenethyl ester (CAPE) protect the heart? Mol Cell Biochem 273: 169-175, 2005.
53. Panagia M, Schneider JE, Brown B, Cole MA, Clarke K. Abnormal function and glucose metabolism in the type-2 diabetic db/db mouse heart. Can J Physiol Pharmacol 85: 289-294, 2007.
54. Paulson DJ. The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res 34: 104-112, 1997.
55. Portha B. Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabetes Metab Res Rev 21: 495-504, 2005.
56. Portha B, Serradas P, Bailbe D, Suzuki K, Goto Y, Giroix MH. Beta-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes 40: 486-491, 1991.
57. Potdar S, Kavdia M. NO/peroxynitrite dynamics of high glucose-exposed HUVECs: chemiluminescent measurement and computational model. Microvasc Res 78: 191-198, 2009.
58. Raij L. Nitric oxide in the pathogenesis of cardiac disease. J Clin Hypertens (Greenwich) 8: 30-39, 2006.
59. Rijzewijk LJ, van der Meer RW, Lamb HJ, de Jong HW, Lubberink M, Romijn JA, Bax JJ, de Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit JW, Diamant M. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol 54: 1524-1532, 2009.
60. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 52: 1793-1799, 2008.
61. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, Radda GK, Neubauer S, Clarke K. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107: 3040-3046, 2003.
62. Schrauwen P, Schrauwen-Hinderling V, Hoeks J, Hesselink MK. Mitochondrial dysfunction and lipotoxicity. Biochim Biophys Acta 1801: 266-271, 2010.
63. Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 49: 417-423, 2003.
64. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation 105: 1727-1733, 2002. (Pubitemid 34298619)
65. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2: 997-1000, 1989. (Pubitemid 19257913)
66. van der Meer RW, Rijzewijk LJ, Diamant M, Hammer S, Schar M, Bax JJ, Smit JW, Romijn JA, de Roos A, Lamb HJ. The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function. Eur Heart J 29: 1516-1522, 2008. (Pubitemid 351881987)
67. Vincent HK, Powers SK, Dirks AJ, Scarpace PJ. Mechanism for obesity-induced increase in myocardial lipid peroxidation. Int J Obes Relat Metab Disord 25: 378-388, 2001. (Pubitemid 32209814)
68. Wang P, Chatham JC. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 286: E725-E736, 2004. (Pubitemid 38506943)
69. Wang P, Lloyd SG, Zeng H, Bonen A, Chatham JC. Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 288: H2102-H2110, 2005. (Pubitemid 40604093)
70. Xiao DS, Jiang L, Che LL, Lu L. Nitric oxide and iron metabolism in exercised rat with L-arginine supplementation. Mol Cell Biochem 252: 65-72, 2003. (Pubitemid 37220733)
71. Xuan YT, Tang XL, Qiu Y, Banerjee S, Takano H, Han H, Bolli R. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 279: H2360-H2371, 2000.
72. Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, Epstein PN. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 53: 1336-1343, 2004. (Pubitemid 38569021)
73. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Woo-Soo S, Nishikawa J, Sasaki Y, Omata M. Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM. Diabetes 47: 119-124, 1998. (Pubitemid 28030817)
74. Zhang LP, Yang CY, Wang YP, Cui F, Zhang Y. Protective effect of polydatin against ischemia/reperfusion injury in rat heart. Sheng Li Xue Bao 60: 161-168, 2008.